Evidence map›Paper›PMID 25968054›Full record

ArticleNature communications2015

Reinforcement of STAT3 activity reprogrammes human embryonic stem cells to naive-like pluripotency.

Hongwei Chen, Irène Aksoy, Fabrice Gonnot, Pierre Osteil, Maxime Aubry, Claire Hamela, Cloé Rognard, Arnaud Hochard, Sophie Voisin, Emeline Fontaine and 18 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 90 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
90citing papers in PubMed, 2 pooled it
9.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

90 citing papers in PubMed, 2 syntheses or guidelines pooled it, 163 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. H3K27ac Is Essential for Human Naive Pluripotency Modulated by m6A-Driven EP300 Expression.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

30 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors at 5 institutions in 2 countries.

Hongwei Chen1] INSERM, U846, Stem Cell and Brain Research Institute, 18 Avenue Doyen Lépine, Bron F-69500, France [2] Université de Lyon, Lyon 138672, France.
Irène Aksoy1] INSERM, U846, Stem Cell and Brain Research Institute, 18 Avenue Doyen Lépine, Bron F-69500, France [2] Université de Lyon, Lyon 138672, France [3] Stem Cell and Developmental Biology, Genome Institute of Singapore, Singapore 138672, Singapore.
Fabrice Gonnot1] INSERM, U846, Stem Cell and Brain Research Institute, 18 Avenue Doyen Lépine, Bron F-69500, France [2] Université de Lyon, Lyon 138672, France.
Pierre Osteil1] INSERM, U846, Stem Cell and Brain Research Institute, 18 Avenue Doyen Lépine, Bron F-69500, France [2] Université de Lyon, Lyon 138672, France.
Maxime Aubry1] INSERM, U846, Stem Cell and Brain Research Institute, 18 Avenue Doyen Lépine, Bron F-69500, France [2] Université de Lyon, Lyon 138672, France.
Claire Hamela1] INSERM, U846, Stem Cell and Brain Research Institute, 18 Avenue Doyen Lépine, Bron F-69500, France [2] Université de Lyon, Lyon 138672, France.
Cloé Rognard1] INSERM, U846, Stem Cell and Brain Research Institute, 18 Avenue Doyen Lépine, Bron F-69500, France [2] Université de Lyon, Lyon 138672, France.
Arnaud Hochard1] INSERM, U846, Stem Cell and Brain Research Institute, 18 Avenue Doyen Lépine, Bron F-69500, France [2] Université de Lyon, Lyon 138672, France.
Sophie Voisin1] INSERM, U846, Stem Cell and Brain Research Institute, 18 Avenue Doyen Lépine, Bron F-69500, France [2] Université de Lyon, Lyon 138672, France [3] INRA, USC1361, 18 Avenue Doyen Lépine, Bron F-69500, France.
Emeline Fontaine1] INSERM, U846, Stem Cell and Brain Research Institute, 18 Avenue Doyen Lépine, Bron F-69500, France [2] Université de Lyon, Lyon 138672, France.ORCID 0000000268858869
Magali Mure1] INSERM, U846, Stem Cell and Brain Research Institute, 18 Avenue Doyen Lépine, Bron F-69500, France [2] Université de Lyon, Lyon 138672, France.
Marielle Afanassieff1] INSERM, U846, Stem Cell and Brain Research Institute, 18 Avenue Doyen Lépine, Bron F-69500, France [2] Université de Lyon, Lyon 138672, France [3] INRA, USC1361, 18 Avenue Doyen Lépine, Bron F-69500, France.
Elouan ClerouxUMR 7242 Biotechnology and Cell Signaling, University of Strasbourg, CNRS, 300 Boulevard Sébastien Brant, BP 10413, Illkirch F-67412, France.
Sylvain GuibertUMR 7242 Biotechnology and Cell Signaling, University of Strasbourg, CNRS, 300 Boulevard Sébastien Brant, BP 10413, Illkirch F-67412, France.
Jiaxuan ChenStem Cell and Developmental Biology, Genome Institute of Singapore, Singapore 138672, Singapore.
Céline VallotUMR7216 Epigenetics and Cell Fate, CNRS, University of Paris Diderot, Sorbonne Paris Cité, Paris F-75013, France.
Hervé AcloqueINRA, UMR1388 Génétique, Physiologie et Systèmes d'Elevage, Castanet Tolosan F-31326, France.
Clémence GenthonINRA, UMR1388 Génétique, Physiologie et Systèmes d'Elevage, Castanet Tolosan F-31326, France.
Cécile DonnadieuINRA, UMR1388 Génétique, Physiologie et Systèmes d'Elevage, Castanet Tolosan F-31326, France.
John De Vos1] INSERM, U1040, Montpellier F-34000, France [2] CHU Montpellier, Institute for Research in Biotherapy, Hôpital Saint-Eloi, Montpellier F-34000, France.ORCID 0000000318804130
Damien SanlavilleDepartment of Genetics, Lyon University Hospital, CNRS UMR 5292, INSERM U1028, Bron F-69500, France.
Jean-François Guérin1] INSERM, U846, Stem Cell and Brain Research Institute, 18 Avenue Doyen Lépine, Bron F-69500, France [2] Université de Lyon, Lyon 138672, France.
Michael WeberUMR 7242 Biotechnology and Cell Signaling, University of Strasbourg, CNRS, 300 Boulevard Sébastien Brant, BP 10413, Illkirch F-67412, France.
Lawrence W StantonStem Cell and Developmental Biology, Genome Institute of Singapore, Singapore 138672, Singapore.
Claire RougeulleUMR7216 Epigenetics and Cell Fate, CNRS, University of Paris Diderot, Sorbonne Paris Cité, Paris F-75013, France.
Bertrand Pain1] INSERM, U846, Stem Cell and Brain Research Institute, 18 Avenue Doyen Lépine, Bron F-69500, France [2] Université de Lyon, Lyon 138672, France [3] INRA, USC1361, 18 Avenue Doyen Lépine, Bron F-69500, France.
Pierre-Yves Bourillot1] INSERM, U846, Stem Cell and Brain Research Institute, 18 Avenue Doyen Lépine, Bron F-69500, France [2] Université de Lyon, Lyon 138672, France.
Pierre Savatier1] INSERM, U846, Stem Cell and Brain Research Institute, 18 Avenue Doyen Lépine, Bron F-69500, France [2] Université de Lyon, Lyon 138672, France.
Université Claude Bernard Lyon 1 · FRCentre National de la Recherche Scientifique · FRGénétique Physiologie et Systèmes d'Elevage · FRGenome Institute of Singapore · SGInserm · FR

Funding

European Research Council 206875
6 · The paper itself

Abstract

Leukemia inhibitory factor (LIF)/STAT3 signalling is a hallmark of naive pluripotency in rodent pluripotent stem cells (PSCs), whereas fibroblast growth factor (FGF)-2 and activin/nodal signalling is required to sustain self-renewal of human PSCs in a condition referred to as the primed state. It is unknown why LIF/STAT3 signalling alone fails to sustain pluripotency in human PSCs. Here we show that the forced expression of the hormone-dependent STAT3-ER (ER, ligand-binding domain of the human oestrogen receptor) in combination with 2i/LIF and tamoxifen allows human PSCs to escape from the primed state and enter a state characterized by the activation of STAT3 target genes and long-term self-renewal in FGF2- and feeder-free conditions. These cells acquire growth properties, a gene expression profile and an epigenetic landscape closer to those described in mouse naive PSCs. Together, these results show that temporarily increasing STAT3 activity is sufficient to reprogramme human PSCs to naive-like pluripotent cells.

Indexed as

AnimalsEmbryonic Stem CellsFeeder CellsFibroblast Growth Factor 2FibroblastsGene Expression RegulationHumansLeukemia Inhibitory FactorMicePluripotent Stem CellsProtein Array AnalysisSignal TransductionSTAT3 Transcription FactorTamoxifenFibroblast Growth Factor 2Leukemia Inhibitory FactorLIF protein, humanSTAT3 protein, humanSTAT3 Transcription FactorTamoxifen

Identifiers

PMID25968054
PMCPMC4479042
OpenAlexW2265343025

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.